Combinostics at ASNR22

May 16-18, 2022  |  New York, NY
Booth #109

Did you miss our team at ASNR22 or want to discuss our products further? Schedule some time to learn more about how our cNeuro® suite, including the cMRI™ and cDSI™ applications, is a complete AI software solution for entire patient care pathways of major neurological disorders. Our comprehensive suite supports early detection, differentiation of diagnosis, treatment planning and monitoring.

Join us for a presentation at ASNR22.

Tuesday, May 17 | 3:05 pm

Differential diagnosis of dementias: MRI only diagnostic trend to enable differentiation with imaging alone

Presenter: Peter Ngum, Clinical Application Specialist
Location: Rhinelander (2nd Floor)

Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.

Our cNeuro® suite puts the focus on patients by providing clinicians with objective, systematic insights for confident, evidence-based diagnostic and management decisions.

Patient data from multiple sources are integrated and compared with data from previous patients and healthy controls: demographic information, imaging (cMRI) and other biomarkers, clinical characteristics, and neuropsychology tests. 

Applications in the cNeuro® suite:

*WIP – not yet cleared for clinical use.
Play Video
Play Video


Our AI-driven software tools support early detection, differential diagnosis, prediction of progression, and monitoring of neurodegenerative disorders.


cMRI provides fully automated brain MRI quantification for increased throughput, greater objectivity, and high-quality reporting for improved patient care.

Play Video